Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $11.82 million. The enterprise value is $4.38 million.
| Market Cap | 11.82M |
| Enterprise Value | 4.38M |
Important Dates
The next estimated earnings date is Friday, July 17, 2026, before market open.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 3.81 million shares outstanding. The number of shares has increased by 1,688.07% in one year.
| Current Share Class | 3.81M |
| Shares Outstanding | 3.81M |
| Shares Change (YoY) | +1,688.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 5.28% |
| Float | 2.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.62
| Current Ratio | 14.62 |
| Quick Ratio | 12.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -655.06 |
Financial Efficiency
Return on equity (ROE) is -58.62% and return on invested capital (ROIC) is -32.95%.
| Return on Equity (ROE) | -58.62% |
| Return on Assets (ROA) | -31.33% |
| Return on Invested Capital (ROIC) | -32.95% |
| Return on Capital Employed (ROCE) | -36.81% |
| Weighted Average Cost of Capital (WACC) | 13.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$578,035 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.90% in the last 52 weeks. The beta is 1.65, so PBM's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -89.90% |
| 50-Day Moving Average | 4.93 |
| 200-Day Moving Average | 8.88 |
| Relative Strength Index (RSI) | 40.16 |
| Average Volume (20 Days) | 75,828 |
Short Selling Information
The latest short interest is 33,547, so 0.88% of the outstanding shares have been sold short.
| Short Interest | 33,547 |
| Short Previous Month | 25,988 |
| Short % of Shares Out | 0.88% |
| Short % of Float | 1.29% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.24M |
| Pretax Income | -6.94M |
| Net Income | -6.94M |
| EBITDA | -6.23M |
| EBIT | -6.24M |
| Earnings Per Share (EPS) | -$12.56 |
Balance Sheet
The company has $7.44 million in cash and n/a in debt, with a net cash position of $7.44 million or $1.95 per share.
| Cash & Cash Equivalents | 7.44M |
| Total Debt | n/a |
| Net Cash | 7.44M |
| Net Cash Per Share | $1.95 |
| Equity (Book Value) | 16.94M |
| Book Value Per Share | 7.39 |
| Working Capital | 8.49M |
Cash Flow
In the last 12 months, operating cash flow was -$8.14 million and capital expenditures -$229, giving a free cash flow of -$8.14 million.
| Operating Cash Flow | -8.14M |
| Capital Expenditures | -229 |
| Depreciation & Amortization | 5,266 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.14M |
| FCF Per Share | -$2.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PBM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,688.07% |
| Shareholder Yield | -1,688.07% |
| Earnings Yield | -58.66% |
| FCF Yield | -68.87% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:6.25.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:6.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |